Update: On August 31, 2020, Centers for Medicare & Medicaid Services (CMS) stated that CMS is releasing the enrollment suspension for contract H5322 effective January 1, 2021. Additionally, CMS will allow Care Improvement Plus to offer plans under contract H5322 to new beneficiaries during the CY 2021 Annual Election Period (AEP), which will be held between October 15, 2020 and December 7, 2020.
Read the CMS sanction release notice:
https://www.cms.gov/files/document/care-improvement-plus-sanction-release-09012020.pdf
CMS Notice of Enrollment Suspension for Medicare Advantage-Prescription Drug Contract Number H5322 (Care Improvement Plus) for plan year 2020
On September 11, 2019, the Centers for Medicare & Medicaid Services (CMS) provided notice to Care Improvement Plus South Central Insurance Company ("Care Improvement Plus") that CMS made a determination to prohibit the enrollment of new beneficiaries under the Medicare Advantage-Prescription Drug (MA-PD) contract H5322 for contract year (CY) 2020.
As a result of this determination, Care Improvement Plus will be prohibited from accepting any MA-PD plan enrollments which would be effective January 1, 2020, through December 1, 2020. This action will include the removal of H5322 from the list of MA-PD plans from which beneficiaries may make an election during the CY 2020 Annual Election Period (AEP), which runs between October 15, 2019, and December 7, 2019. However, Care Improvement Plus
may continue to accept and process enrollments that become effective on or before December 1, 2019.
Current members of Medicare plans under this contract (H5322) are not
affected by the sanctions and may remain with their 2019 Medicare plan
into 2020. However, during CY 2020, all individual market plans offered under H5322 will be precluded from accepting any new enrollees, including those beneficiaries already enrolled in a Care Improvement Plus MA-PD plan who may want to elect a different plan offered under the same contract.